Grant: CIHR Fellowship
McGill University
$135,000.00
Mitochondrial translation defects in neurodegenerative disease
FY 2009-10
Summary
All cells in the body require a steady source of chemical energy to carry out their normal physiological functions. The majority of this chemical energy, which is packaged as a compound called ATP, is produced by the oxidation of carbohydrate and fat in a biochemical process called oxidative phosphorylation. This process takes place in a compartment of the cell called the mitochondrion, and is carried out by several large protein complexes that constitute the mitochondrial respiratory chain. Respiratory chain dysfunction interferes with the normal supply of energy, and this produces a wide variety of different diseases, the nature and severity of which depend on the exact genetic defect. The genetics of respiratory chain diseases is complicated by the fact that some components of the system are encoded in nuclear genes, while others are encoded in the small genome that is contained within the mitochondria themselves. Because a number of respiratory chain proteins are encoded in mitochondria, these organelles must maintain a system for translating these genes into protein products. Defects in this translation apparatus can cause multi-respiratory complex diseases in humans; however, the mechanisms underlying the activation and termination of mitochondrial translation are poorly understood.
The aim of this proposal is to identify the mechanisms governing the activation and termination of mitochondrial translation via a variety of molecular techniques. Characterization of these processes should provide a huge advance in our knowledge of mitochondrial translation in humans, its relationship with disease and ultimately lead to the development of an in vitro system to study the regulation of mammalian mitochondrial translation.
Department
Program
CIHR Fellowship
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
203518
Name
Gawryluk Ryan M
Region
Québec
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Genetics
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Mitochondrial translation defects in neurodegenerative disease
Programtype2
Fellowship Programs
Orgnameinp2
McGill University
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Biochemical Genetics; Mammalian Cell Culture; Mitochondrial Disease; Mitochondrial Translation; Molecular Genetics; Oxidative Phosphorylation
Abstract
All cells in the body require a steady source of chemical energy to carry out their normal physiological functions. The majority of this chemical energy, which is packaged as a compound called ATP, is produced by the oxidation of carbohydrate and fat in a biochemical process called oxidative phosphorylation. This process takes place in a compartment of the cell called the mitochondrion, and is carried out by several large protein complexes that constitute the mitochondrial respiratory chain. Respiratory chain dysfunction interferes with the normal supply of energy, and this produces a wide variety of different diseases, the nature and severity of which depend on the exact genetic defect. The genetics of respiratory chain diseases is complicated by the fact that some components of the system are encoded in nuclear genes, while others are encoded in the small genome that is contained within the mitochondria themselves. Because a number of respiratory chain proteins are encoded in mitochondria, these organelles must maintain a system for translating these genes into protein products. Defects in this translation apparatus can cause multi-respiratory complex diseases in humans; however, the mechanisms underlying the activation and termination of mitochondrial translation are poorly understood.
The aim of this proposal is to identify the mechanisms governing the activation and termination of mitochondrial translation via a variety of molecular techniques. Characterization of these processes should provide a huge advance in our knowledge of mitochondrial translation in humans, its relationship with disease and ultimately lead to the development of an in vitro system to study the regulation of mammalian mitochondrial translation.
Competitiondate
201002
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Gawryluk, Ryan M
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~